A funded networking event on vascular liver diseases and associated complications is being organised to give an update on current clinical and scientific concepts, as well as open questions in the field of vascular liver diseases. This workshop has received funding support from the EJP RD’s Networking Support Scheme (NSS) funding opportunity as part of the…
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for to support natural history studies for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will substantially contribute to the approval of new products, or new indications for already…
The Swiss Rare Disease Registry at the University of Berne is offering a funded PhD contract as part of the Screen4Care project, a public-private collaboration of 35 partners funded by the European Commission’s Innovative Medicines Initiative. Screen4Care aims to shorten the time required for rare disease diagnosis and efficient intervention by utilizing genetic newborn screening…
In the context of EJP RD’s ERN Workshops, an in-person workshop titled « Trans-ERN Working Group for Spina Bifida (Spinal Dysraphism): Workshop for future research on innovative diagnostics and interdisciplinary treatment » aimed at sharing participants’ expertise on research in different areas of spinal dysraphism and opening the way to new research projects is being organised by Centre de Référence Spina…
Following a sustained campaign by rare disease patient advocacy organisations such as Rare Diseases International and with the support of several Member States, the United Nations (UN) General Assembly has formally adopted on December 16th 2021 with the consensus of all 193 UN Member States the UN Resolution on Addressing the Challenges of Persons Living with a Rare…
The recently released report of the 2021 European Research and Innovation Days organised in June 2021 by the European Commission presents the main conclusion from the 21,000 participants and 200 high-level speakers: The report contains summaries and quotes from the event’s 70 online live sessions and workshops, as well as from over 200 consultations between…
We are glad to announce today (December 14th 2021) the official launch of the Joint Transnational Call 2022, a funding opportunity for research projects on the development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases. The aim of the funding opportunity is to enable scientists in different…
The European Medicines Agency (EMA) is organising a virtual event on « Research in regulatory science – addressing the needs » to inform the public and stakeholders about regulatory science research needs and how stakeholders can engage with these regulatory science research needs. The webinar will take place on January 18th 2022 from 10.00 – 12.00 CET. Gaps exist in regulatory science that…
Similar to its upcoming Scientific Call for Proposals 2022, the French Muscular Dystrophy Association (AFM-Téléthon) will soon launch its a Medical Research Call for Proposals in Neuromuscular Disorders. Open to both French and foreign teams, the objective of the call is to support medical research projects whose aim is to improve the care and management of patients,…
Based on the results of this year’s Téléthon fund-raising event, the French Muscular Dystrophy Association (AFM-Téléthon) will soon launch its annual Call for Proposals. The Scientific Call for Proposals 2022 is open to both French and foreign teams and aims to support research with a particular focus on therapeutic and technological projects applicable to several…